Product screening
Antibodies
Proteins
Cot （phospho Thr290） Polyclonal Antibody
Alias:MAP3K8;COT;ESTF;Mitogen-activated protein kinase kinase kinase 8;Cancer Osaka thyroid oncogene;Proto-oncogene c-Cot;Serine/threonine-protein kinase cot;Tumor progression locus 2;TPL-2
CatalogNo:HJRLP0867
Specifications
50μL;100μL
Delivery date
Spot
Target
Cot
Reactivity
Human,Mouse,Rat
Application - After Update
WB,IHC,IF,ELISA
MW(Observed)
60kD
Host Species
Rabbit
Isotype
IgG
Modify
Phospho
Recommended dilution ratio
WB 1:500-1:2000;IHC 1:100-1:300;IF 1:200-1:1000;ELISA 1:40000;Not yet tested in other applications.
compose
Liquid in PBS containing 50％ glycerol, 0.5％ BSA and 0.02％ sodium azide.
Store
-15°C to -25°C/1 year（Do not lower than -25°C）
Soncentration
1 mg/ml
Clonality
Polyclonal
Immunogen
The antiserum was produced against synthesized peptide derived from human COT around the phosphorylation site of Thr290. AA range:256-305
Specificity
Phospho-Cot （T290） Polyclonal Antibody detects endogenous levels of Cot protein only when phosphorylated at T290.
Gene name
MAP3K8
Protein name
Mitogen-activated protein kinase kinase kinase 8
Organism-1
Human